Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Late second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 70-year-old male patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (Received 1st dose of vaccine on 9th January 2024 with batch number C4325 and expiry date 16-SEP-2025). The patient did not receive the 2nd dose of Shingrix. The patient had incomplete course of vaccination (Verbatim: Late second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 17-SEP-2025 A pharmacist called to report that a patient had received the first dose of Shingrix on 9th January 2024. The pharmacist inquired whether the series needed to be restarted or if revaccination was required. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.